Purpose: This study examined whether older age moderates the association between gender-affirming medical treatment and quality of life (QOL) among transgender individuals.
Methods: Transgender men and women from the National Transgender Discrimination Survey who had either recently or never undergone medical treatment were included (n = 2420). A moderation analysis was utilized.
Results: As predicted, participants who initiated medical treatment had higher QOL than those who did not. Age moderated this association. The QOL difference was greater for older than for younger transgender individuals.
Conclusion: Among all transgender men and women, gender-affirming medical treatment can be especially beneficial for elders.
Keywords: aging; gender-affirming medical treatment; quality of life; transgender.